Publications

5813 Results

Sex differences in chemotherapy completion and adverse events among patients with colon cancer (CALGB/SWOG 80702) (Alliance)

Authors
E. Cheng
Journal / Conference
ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il), #3624 poster
Year
2025
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80702

Association between empirical dietary inflammatory pattern (EDIP) and survival in patients with stage III colon cancer: Findings from CALGB/SWOG 80702 (Alliance)

Authors
S.K. Char
Journal / Conference
ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il), #LBA3509
Year
2025
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80702

Pragmatica-Lung (SWOG S2302): A prospective pragmatic randomized study of ramucirumab plus pembrolizumab versus standard of care for participants previously treated with immunotherapy for stage IV or recurrent non-small cell lung cancer

Authors
K.H. Dragnev
Journal / Conference
ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il), #LBA8671
Year
2025
Research Committee(s)
Lung
Study Number(s)
S2302

Validation and refinement of Society of Immunotherapy of Cancer (SITC) definitions for PD-(L)1 resistance: An analysis of more than 1,300 participants from SWOG

Authors
M. Othus
Journal / Conference
ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il), #2656 poster
Year
2025
Research Committee(s)
Early Therapeutics and Rare Cancers and Melanoma
Study Number(s)
S1404, S1609

Long non-coding RNA (lncRNA) SNHG11 as a prognostic and predictive biomarker in metastatic colorectal cancer (mCRC): Insights from CALGB (Alliance)/SWOG 80405

Authors
M. Bartolini
Journal / Conference
ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il), #3128 poster
Year
2025
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

Small nucleolar RNAs (snoRNAs) expression and effects on patient (pt) outcomes in metastatic colorectal cancer (mCRC): Data from CALGB (Alliance)/SWOG 80405

Authors
F. Battaglin
Journal / Conference
ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il), #3145 poster
Year
2025
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

Abstract 2787: Effect of miR-494 modulation in colorectal cancer (CRC): Clinical outcome, target expression and cell characteristics

Authors
Pooja Mittal
Journal / Conference
AACR 2025; Journal: Cancer Research, Cancer Res (2025) 85 (8_Supplement_1): 2787
Year
2025
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

IMPACT OF EBV STATUS AND HISTOLOGY ON OUTCOMES WITH NIVOLUMAB-AVD VERSUS Bv-AVD IN PATIENTS ENROLLED ON SWOG S1826

Authors
S. Ahmed
Journal / Conference
ICML 2025 Meeting (Lugano, Switzerland, from 17 to 21 June 2025), e20_70093
Year
2025
Research Committee(s)
Lymphoma
Study Number(s)
S1826

HEALTH-RELATED QUALITY OF LIFE (HRQoL) ENDPOINTS OF THE PHASE III INTERGROUP S1826 ADVANCED-STAGE, CLASSIC HODGKIN LYMPHOMA (cHL) TRIAL

Authors
J. M. Unger
Journal / Conference
ICML 2025 Meeting (Lugano, Switzerland, from 17 to 21 June 2025), e127_70093
Year
2025
Research Committee(s)
Lymphoma
Study Number(s)
S1826

THE ASSOCIATION OF SOCIAL DISADVANTAGE WITH OUTCOMES IN PATIENTS WITH ADVANCED-STAGE, CLASSIC HODGKIN LYMPHOMA ENROLLED IN THE PHASE 3 INTERGROUP TRIAL S1826

Authors
J. M. Kahn
Journal / Conference
ICML 2025 Meeting (Lugano, Switzerland, from 17 to 21 June 2025), e368_70093
Year
2025
Research Committee(s)
Lymphoma
Study Number(s)
S1826